RAF1 and neoplasm: EGFR signaling activates a network of downstream pathways, including the phosphoinositide 3-kinase (PI3K)/Akt [4], [5] and Ras/Raf/ERK1/2 [6], [7] pathways, which promote tumor cell proliferation, invasion, metastasis, angiogenesis and apoptosis resistance.